StockData
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. (PCRX) stock

PCRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3034% above fair value
$36.34+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.45BP/E 103.8Yield –

Pacira BioSciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Pacira BioSciences's market cap was $1.45B on Nov 11, 2026, against $1.01B a year earlier. Over the last 5 years it ranged from $694.07M to $3.41B, with a median of $1.33B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.45B+30.6%
2025Dec 31, 2025$1.11B+27.9%
2024Dec 31, 2024$869.43M-44.5%
2023Dec 29, 2023$1.57B-11.5%
2022Dec 30, 2022$1.77B-33.9%
2021Dec 31, 2021$2.68B+3.4%
2020Dec 31, 2020$2.59B+37.2%
2019Dec 31, 2019$1.89B+6.9%
2018Dec 31, 2018$1.77B-4.6%
2017Dec 29, 2017$1.85B+53.8%
2016Dec 30, 2016$1.20B-57.3%
2015Dec 31, 2015$2.82B-11.7%
2014Dec 31, 2014$3.19B+65.8%
2013Dec 31, 2013$1.93B+239.5%
2012Dec 31, 2012$567.47M+280.8%
2011Dec 30, 2011$149.03M–

More Pacira BioSciences figures

See a number that looks wrong?